ITRM920506A1 - Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi. - Google Patents

Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.

Info

Publication number
ITRM920506A1
ITRM920506A1 IT000506A ITRM920506A ITRM920506A1 IT RM920506 A1 ITRM920506 A1 IT RM920506A1 IT 000506 A IT000506 A IT 000506A IT RM920506 A ITRM920506 A IT RM920506A IT RM920506 A1 ITRM920506 A1 IT RM920506A1
Authority
IT
Italy
Prior art keywords
pct
lpg
complexes
antibodies against
antigenic regions
Prior art date
Application number
IT000506A
Other languages
English (en)
Inventor
Giulio Tarro
Original Assignee
Ist Farmacoterapico It Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Farmacoterapico It Spa filed Critical Ist Farmacoterapico It Spa
Publication of ITRM920506A0 publication Critical patent/ITRM920506A0/it
Priority to ITRM920506A priority Critical patent/IT1262954B/it
Priority to KR1019940704823A priority patent/KR100237250B1/ko
Priority to ES93916141T priority patent/ES2111757T3/es
Priority to BR9306663A priority patent/BR9306663A/pt
Priority to EP93916141A priority patent/EP0649433B1/en
Priority to DK93916141T priority patent/DK0649433T3/da
Priority to AT93916141T priority patent/ATE160359T1/de
Priority to JP6503153A priority patent/JP2958118B2/ja
Priority to CA002139518A priority patent/CA2139518C/en
Priority to DE69315341T priority patent/DE69315341T2/de
Priority to RU94046337A priority patent/RU2141969C1/ru
Priority to US08/351,284 priority patent/US5747643A/en
Priority to AU45823/93A priority patent/AU680198B2/en
Priority to PCT/IT1993/000069 priority patent/WO1994001458A1/en
Publication of ITRM920506A1 publication Critical patent/ITRM920506A1/it
Priority to US08/667,970 priority patent/US5759792A/en
Priority to US08/667,971 priority patent/US5877294A/en
Application granted granted Critical
Publication of IT1262954B publication Critical patent/IT1262954B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ITRM920506A 1992-07-03 1992-07-03 Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi. IT1262954B (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
ITRM920506A IT1262954B (it) 1992-07-03 1992-07-03 Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.
CA002139518A CA2139518C (en) 1992-07-03 1993-07-01 Antigenic regions of tlp complexes and antibodies against the same
RU94046337A RU2141969C1 (ru) 1992-07-03 1993-07-01 Антигенные пептиды, способ обнаружения выделяемых опухолями частиц
BR9306663A BR9306663A (pt) 1992-07-03 1993-07-01 Regiões antigênicas de complexos de partículas liberadas por tumores (TLP) e anticorpos contra os mesmos
EP93916141A EP0649433B1 (en) 1992-07-03 1993-07-01 Antigenic regions of tumour-liberated particles (tlp) complexes and antibodies against them
DK93916141T DK0649433T3 (da) 1992-07-03 1993-07-01 Antigeniske regioner fra komplekser af tumorfrigivne partikler (TLP) og antistoffer mod sådanne.
AT93916141T ATE160359T1 (de) 1992-07-03 1993-07-01 Antigene regionen von tumorfreigestzten partikeln (tlp) komplexen und antikörper die sie erkennen.
JP6503153A JP2958118B2 (ja) 1992-07-03 1993-07-01 腫瘍放出粒子（ｔｌｐ）複合体の抗原性領域とそれらに対する抗体
KR1019940704823A KR100237250B1 (ko) 1992-07-03 1993-07-01 Tlp 복합체에 대한 항원성 부위와 이의 항체
DE69315341T DE69315341T2 (de) 1992-07-03 1993-07-01 Antigene regionen von tumorfreigestzten partikeln (tlp) komplexen und antikörper die sie erkennen.
ES93916141T ES2111757T3 (es) 1992-07-03 1993-07-01 Regiones antigenicas de complejos de particulas liberadas por tumores (tlp) y anticuerpos contra los mismos.
US08/351,284 US5747643A (en) 1992-07-03 1993-07-01 Antigenic regions of tumor-liberated particles (TLP) complexes and antibodies against the sames
AU45823/93A AU680198B2 (en) 1992-07-03 1993-07-01 Antigenic regions of tumour-liberated particles (TLP) complexes and antibodies against them
PCT/IT1993/000069 WO1994001458A1 (en) 1992-07-03 1993-07-01 Antigenic regions of tumour-liberated particles (tlp) complexes and antibodies against them
US08/667,970 US5759792A (en) 1992-07-03 1996-06-19 Antigenic regions of tumour-liberated particles (TLP) complexes and antibodies against the same
US08/667,971 US5877294A (en) 1992-07-03 1996-06-19 Antigenic regions of tumor-liberated particles (TLP) complexes and antibodies against the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920506A IT1262954B (it) 1992-07-03 1992-07-03 Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.

Publications (3)

Publication Number Publication Date
ITRM920506A0 ITRM920506A0 (it) 1992-07-03
ITRM920506A1 true ITRM920506A1 (it) 1994-01-03
IT1262954B IT1262954B (it) 1996-07-23

Family

ID=11401092

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920506A IT1262954B (it) 1992-07-03 1992-07-03 Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.

Country Status (14)

Country Link
US (3) US5747643A (it)
EP (1) EP0649433B1 (it)
JP (1) JP2958118B2 (it)
KR (1) KR100237250B1 (it)
AT (1) ATE160359T1 (it)
AU (1) AU680198B2 (it)
BR (1) BR9306663A (it)
CA (1) CA2139518C (it)
DE (1) DE69315341T2 (it)
DK (1) DK0649433T3 (it)
ES (1) ES2111757T3 (it)
IT (1) IT1262954B (it)
RU (1) RU2141969C1 (it)
WO (1) WO1994001458A1 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1284870B1 (it) * 1996-07-10 1998-05-22 Ist Farmacoterapico It Spa Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi
IT1294967B1 (it) * 1996-10-09 1999-04-23 Ist Farmacoterapico It Spa Composizione immunogenica da tlp
US20030157116A1 (en) * 2000-02-25 2003-08-21 Giulio Tarro Tlp peptides and dna sequences coding the same
IT1317853B1 (it) * 2000-02-25 2003-07-15 Unihart Corp Peptidi tlp e sequenze di dna che li codificano.
UA76444C2 (en) 2001-02-14 2006-08-15 Composition of biochemical compounds involved in bioenergy metabolism of cells and method of its use in prevention and therapy of diseases
RU2216742C2 (ru) * 2002-01-11 2003-11-20 Потин Владимир Всеволодович Способ количественного определения концентрации антител, специфичных к антигенам стероид-продуцирующих клеток человека, в биологических жидкостях человека, содержащих специфичные антитела
CA2593086A1 (en) 2004-12-30 2006-07-06 Vito Michele Fazio Anti-tumoral immunogenic peptides and vaccine thereof
US20100255514A1 (en) 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
CA2733672C (en) * 2007-08-16 2018-09-11 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
EP3167898A1 (en) 2015-11-11 2017-05-17 IEO - Istituto Europeo di Oncologia Srl Method for obtaining tumor peptides and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8800604A1 (es) * 1985-04-22 1987-11-16 Hybritech Inc Un metodo para producir anticuerpos monoclonales
NO861491L (no) * 1985-04-22 1986-10-23 Hybritech Inc Antistoff, fremgangsmaate for dets fremstilling og anvendelse for deteksjon og diagnose av canser.
IT1206250B (it) * 1987-02-18 1989-04-14 Ist Farmacoterapico It Spa Stiche umane e relativi prodotti metodo per l'estrazione di antigeni di membrana aventi proprieta' immunogene a partire da cellule neopla-
RU2077725C1 (ru) * 1992-03-05 1997-04-20 Любовь Львовна Сольская Способ обнаружения раковоэмбрионального антигена при помощи специального антительного диагностикума

Also Published As

Publication number Publication date
ES2111757T3 (es) 1998-03-16
RU94046337A (ru) 1996-10-27
IT1262954B (it) 1996-07-23
DK0649433T3 (da) 1998-07-27
CA2139518C (en) 2003-09-23
US5759792A (en) 1998-06-02
AU680198B2 (en) 1997-07-24
US5747643A (en) 1998-05-05
ITRM920506A0 (it) 1992-07-03
ATE160359T1 (de) 1997-12-15
JP2958118B2 (ja) 1999-10-06
CA2139518A1 (en) 1994-01-20
DE69315341D1 (de) 1998-01-02
BR9306663A (pt) 1998-12-08
AU4582393A (en) 1994-01-31
KR950702207A (ko) 1995-06-19
EP0649433B1 (en) 1997-11-19
RU2141969C1 (ru) 1999-11-27
KR100237250B1 (ko) 2000-01-15
DE69315341T2 (de) 1999-03-18
EP0649433A1 (en) 1995-04-26
US5877294A (en) 1999-03-02
WO1994001458A1 (en) 1994-01-20
JPH07508749A (ja) 1995-09-28

Similar Documents

Publication Publication Date Title
ATE163195T1 (de) Lösliche liganden für cd40
ATE182623T1 (de) Humanes serum albumin, herstellung und verwendung
NO965621L (no) Nye hIL-4-mutantproteiner som antagonister eller partielle agonister for det humane interleukin 4
RU94045826A (ru) Моноклональные антитела против рецептора интерферона, с нейтрализующим действием против интерферона типа i
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
DK0765343T3 (da) Monoklonale antistoffer imod CD44v6
NO954320L (no) Lyosfærer omfattende gonadotropin
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
SE8902532D0 (sv) Bestaemning av plasmaproteiner
ATE312909T1 (de) Diagnostika und behandlungen von peridontalen erkrankungen
ITRM920506A1 (it) Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.
ES2053907T3 (es) Pomada topica.
ATE70280T1 (de) Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen.
FR2694296B1 (fr) Peptides inhibant l'activité des protéines ras, préparation et utilisation.
AU9363398A (en) Hepatitis c receptor protein cd81
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
DE59206628D1 (en) Expression signalpeptid-freier staphylokinasen
DE69302375D1 (de) Kosmetische zusammensetzung zur erhaltung der frisur enthaltend ein milchprotein und/oder ein milchproteinhydrolysate und ein hydrolysate
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
DE59006159D1 (de) Verwendung von macrolactonen als antiallergica.
ATE317021T1 (de) Antisense modulierung von lfa-3
EP1103561A4 (en) HLA-A2 RESTRICTED TUMORANTIGEN PEPTIDE DERIVED FROM SART-1
DE69130675D1 (de) Klonierung und expression eines rhoptry-assoziierten proteins aus p. falciparum
AU653332B2 (en) Synthetic peptides which contain sequences from factor VIIa, and the use thereof
ATE175422T1 (de) Schweineadipozytenantigene und ihre verwendung zur immunologischen kontrolle von fett

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960724